Jean Duvall

Patients

During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.

News

FDA has approved the 2026 COVID vaccine formulations, but last year's narrower recommendation stands, leaving open questions about access.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.